Astellas Pharma Inc.JP:4503

Market cap
¥2.68T
P/E ratio
46193.2x
Mar 31,
2010
Mar 31,
2011
Mar 31,
2012
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Revenue981,8991,139,9091,247,2591,372,7061,311,6651,300,3161,306,3481,300,8431,249,5281,296,1631,518,619
Profit (loss) before tax127,115121,975189,683261,770281,769218,113248,967245,350145,324156,886132,361
Profit (loss), attributable to owners of parent92,46490,874135,856193,687218,701164,679222,265195,411120,589124,08698,714
Comprehensive income, attributable to owners of parent158,347182,112169,499130,881174,644198,539222,250156,692181,499208,117205,277
Basic earnings (loss) per share40.2740.4561.589.75103.6981.11115.05104.1564.9367.0854.24
Diluted earnings (loss) per share40.2140.3961.489.62103.5581.02114.94104.0864.967.0554.09
Cash flows from (used in) operating activities150,926214,257187,686313,737235,612312,614258,630221,998306,843257,444327,767
Cash flows from (used in) investing activities-55,101-26,851-71,476-147,050-73,383-121,799-41,757-389,793-81,894-62,413-84,500
Cash flows from (used in) financing activities-110,013-89,395-121,118-193,478-166,153-203,429-233,681181,055-229,479-216,298-195,623